WELCOME - SUMMIT UK 2022
We are delighted to be planning the 10th anniversary edition of The E-Cigarette Summit, London, which will take place on the 18th November 2022. In this milestone year the Summit will provide a unique opportunity to explore how the discussions and evidence on tobacco harm reduction and e-cigarettes has evolved over this decade and examine which questions have been answered, still remain and are emerging.
The role of e-cigarettes and nicotine in society raises both philosophical and scientific questions for regulators and policy makers, but the common goal of ending the smoking epidemic creates a pressing demand to ensure that these discussions are underpinned by scientific evidence and accurate communication.
The E-Cigarette Summit has a single aim of facilitating respectful dialogue and thoughtful analysis of the science from leading independent global experts, and provide a neutral platform to explore how the evidence should be interpreted to deliver the most effective health strategies to end smoking related death and disease. We look forward to celebrating our 10th anniversary with you in November.
We Are Hybrid
The London Summit will be a hybrid event and we aim to maximise the experience for everyone whether you are joining us in person, watching the live stream or catching up later on-demand. All Summit participants will have access to the event app where they can view the Speaker slides and follow the active chat/discussion.
We will “live stream” the Summit as per the Agenda (UK GMT) Individual videos of speaker presentations and the panel discussions will be added to the virtual platform within 24 hours of the live event for you to watch/re-watch later. The app will be live for 3 months after the event.
SUMMIT CHAIR 2022
Prof Ann McNeill
Professor of Tobacco Addiction,
Kings College London
Prof Ann McNeill, Professor of Tobacco Addiction & Vice Dean, Kings College London
SUMMIT SPEAKERS 2021 (2022 COMING SOON)
Paul Lincoln OBE
Chair - Tobacco: preventing uptake, promoting quitting and treating tobacco dependence
(NICE) National Institute of Clinical and Health Excellence -
Dr Colin Mendelsohn MB BS (Hons)
General practitioner, Founding Chairman
Australian Tobacco Harm Reduction Association
Louise Ross
Interim Chair and Mental Health Lead for the New Nicotine Alliance
Business Development Manager - Smoke Free - Quit Smoking Now
Prof Daniel Kotz
Professor in addiction research and clinical epidemiology, Institute of General Practice
Centre for Health and Society, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Germany
Prof Linda Bauld, OBE
Bruce and John Usher Chair in Public Health in the Usher Institute
College of Medicine, University of Edinburgh
Prof Lion Shahab
Professor of Health Psychology
Department of Behavioural Science and Health, University College London
Dr Michael Pesko
Health Economist & Associate Professor
Department of Economics, Andrew Young School of Policy Studies, Georgia State University
Andrea Crossfield MBE
Independent Public Health Consultant and Population Health Policy Specialist
Greater Manchester Health and Social Care Partnership
Prof Alan Boobis, OBE
Emeritus Professor of Toxicology & Chair - UK Committee on Toxicity
Imperial College London
Prof Ann McNeill
Professor of Tobacco Addiction
Institute of Psychiatry, Psychology & Neuroscience,, Kings College London
Kate Pike
Co-ordinator - Trading Standards North West
Member of the Department of Health and Social Care National Tobacco Focus Group
Craig Copland
E-Cigarette Unit Manager - Vigilance and Risk Management of Medicines
MHRA - The Medicines and Healthcare products Regulatory Agency
Dr Debbie Robson RMN, PhD
Senior Lecturer in Tobacco Harm Reduction
National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience, King’s College London
Rosanna O’Connor
Director, Addictions & Inclusion
Office for Health Improvement & Disparities, Department of Health and Social Care
Professor Marcus Munafò
Professor of Biological Psychology and MRC Investigator
School of Psychological Science, University of Bristol
Prof Thomas J. Glynn, PhD
Adjunct Lecturer
Stanford Prevention Research Center, Stanford University School of Medicine
Prof Wayne Hall
Professor Emeritus, National Centre for Youth Substance Use Research
The University of Queensland
Prof Martin Jarvis
Emeritus Professor of Health Psychology, Department of Behavioural Science & Health
University College London
Prof Robert Beaglehole
Emeritus Professor
University of Auckland, New Zealand & Chair ASH - Action for Smokefree 2025, NZ
Prof Robin Mermelstein
Distinguished Professor of Psychology & Director, Institute for Health Research and Policy
University of Illinois, Chicago
Cliff Douglas JD
Director, Tobacco Research Network, Adjunct Professor, Dep't of Health Management and Policy
University of Michigan School of Public Health
Dr Jamie Hartmann-Boyce
Managing Editor, Cochrane Tobacco Addiction Group & Senior Research Fellow
University of Oxford
Dr Konstantinos Farsalinos M.D
External Research Associate
University of Patras, Department of Public and Community Health, University of West Attica, Greece
Prof Peter Hajek
Professor of Clinical Psychology
Wolfson Institute of Public Health, Queen Mary University of London
KEY THEMES TO BE EXPLORED
The E-Cigarette Summit provides an evidence based environment that encourages open and respectful dialogue on the key science and current public health topics. The format includes high level briefings from global experts followed by panel discussions and audience Q&A.
- The UK’s approach to vaping has been notably different from other countries – is the UK a trailblazer or outlier?
- Is youth use a passing fad or a phenomenon that’s here to stay – and what does the Swedish experience tell us?
- How should we define “Tobacco Harm Reduction” and why does language matter?
- What are the new NICE recommendations on e-cigarettes and what are the evidence base and rationale that underpin them?
- What can countries’ experiences with illicit tobacco, marijuana and EVALI teach us about the interplay between regulation and black markets?
- How do we define scientific integrity in the current polarised environment
- Do we need to be clearer about what constitutes a “conflict of interest”
- Can combustible tobacco age-of-sale laws accelerate progress to a Smokefree 2030?
- Are countries and NGOs putting more effort in to regulating/prohibiting non-combustible nicotine products than in addressing combustible products?
- What are the public health lessons of the struggle against Covid-19 and how are these relevant to the struggle to achieve Smokefree 2030?
WHO SHOULD ATTEND
- Regulators and policy/government advisors
- Scientific/academic research community
- Clinical Commissioning Groups/PCT’s
- Smoking cessation practitioners/services
- Health charities and health campaigners
- Public health and tobacco control professionals
- Medical/clinical health practitioners
- Industry and other stakeholders
The Summit independently provides hosted places for vapers and individuals without funding to attend. Please email info@smooth-events.com
WHO SHOULD ATTEND
- Regulators and policy/government advisors
- Scientific/research community
- Smoking cessation practitioners/services
- Health charities and health campaigners
- Public health professionals and academics
- Medical and health practitioners
- Industry and other stakeholders
The Summit independently provides hosted places for vapers and individuals without funding to attend. These places are discretionary and are considered on a case by case basis. If you would like to find out more please contact us by email on info@smooth-events.com
